WST · 10-Q · 2026Q3 · Full report
Operating Cash Flow Trends
WEST PHARMACEUTICAL SERVICES INC · 2026-10-29 · Importance 54 · Surprise 40 · In source text
Net cash provided by operating activities decreased $100.3 million, from $503.7 million to $403.4 million, for the nine months ended September 30, 2026. The decline was primarily driven by increased customer accounts receivable and collection timing, as well as higher inventory levels to support operations. Net cash used in investing activities declined to $7.0 million from $209.8 million, mainly due to SmartDose® 3.5mL sale proceeds and lower capital expenditures. Net cash used in financing activities increased to $715.3 million from $173.4 million, principally because of increased share repurchases.
Key facts
- WEST PHARMACEUTICAL SERVICES INC’s net cash provided by operating activities was $403.4 million for the nine months ended September 30, 2026, down $100.3 million year over year, primarily due to higher customer receivables, collection timing, and inventory levels. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -2.5% | WEST PHARMACEUTICAL SERVICES INC’s net cash provided by operating activities was $403.4 million for the nine months ended September 30,… |